Definium TherapeuticsDFTX
13F holders, Q4 2025 (December 31)8holders
$13.39avg. 13F price*
At the end of Q4 2025, 8 institutions reported holding Definium Therapeutics Inc. (DFTX) in their 13F filings. The largest holders were Driehaus Capital Management LLC ($87.5M), Marshall Wace, LLP ($39.8M) and AWM Investment Company, Inc. ($18.6M).
- Company
- Definium Therapeutics Inc.
- CUSIP
- 24477V105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $150.7M |
| Exits | 0 | $0 |
Ownership 8 holders
| Driehaus Capital Management LLC | 0.59% | New | 6,537,202 | $87.5M |
| Marshall Wace, LLP | 0.04% | New | 2,975,702 | $39.8M |
| AWM Investment Company, Inc. | 1.80% | New | 1,390,662 | $18.6M |
| Ensign Peak Advisors, Inc | 0.01% | New | 262,000 | $3.5M |
| T. Rowe Price Associates Inc. | 0.00% | New | 52,230 | $700K |
| Dark Forest Capital Management LP | 0.02% | New | 30,661 | $411K |
| Sound Income Strategies, LLC | 0.00% | New | 3,690 | $56K |
| Sankala Group LLC | 0.01% | — | 391 | $7K |
"% of holder's portfolio" is DFTX's weight in each manager's 13F, not the share of Definium Therapeutics Inc. the manager owns.